Immunological and biochemical studies and pilot therapeutic trial with ubidecarenone in Kearns-Sayre patients
Bresolin, N.; Bet, L.; Ferrante, C.; Binda, A.; Carenzi, A.; Moggio, M.; Comi, G.; Scarlato, G.
Advances in Neurology 48: 239-256
1988
ISSN/ISBN: 0091-3952 PMID: 3334786 Document Number: 314356
Document emailed within 1 workday
Related Documents
Tamai, A.; Holland, M.G. 1976: Electrophysiological studies on a case of Kearns-Sayre syndrome Nippon Ganka Gakkai Zasshi 80(2): 71-75Byrne, E.; Marzuki, S.; Sattayasai, N.; Dennett, X.; Trounce, I. 1987: Mitochondrial studies in Kearns-Sayre syndrome: normal respiratory chain function with absence of a mitochondrial translation product Neurology 37(9): 1530-1534
Nemet, P.; Godel, V.; Lazar, M. 1982: Kearns-Sayre syndrome Birth Defects Original Article Series 18(6): 263-268
Kokot, W.; Iwaszkiewicz-Bilikiewiczowa, B.; Lewczuk, A.; Sworczak, K. 1996: A case of Kearns-Sayre syndrome Klinika Oczna 98(4): 327-330
Simon, K.; Solti, F.; Sótonyi, P.; Rényi Vámos, F.; Vecsey, T.; Szelier, A. 1989: New aspects of the Kearns-Sayre syndrome Orvosi Hetilap 130(8): 405-409
Usui, M.; Takagi, Y.; Masumoto, H.; Ueda, U. 2002: Pacemaker therapy in Kearns-Sayre syndrome Kyobu Geka. Japanese Journal of Thoracic Surgery 55(13): 1112-1114
Soga, F.; Ueno, S.; Yorifuji, S. 1993: Deletions of mitochondrial DNA in Kearns-Sayre syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 51(9): 2386-2390
Perocchio, M.; Caponnetto, S. 1992: Mitochondrial myopathy and the heart. Kearns-Sayre syndrome Cardiologia 37(5): 373-377
Consalvo, D.; Villegas, F.; Villa, A.M.; Köhler, G.; Molina, H.; Benchuga, E.; Chamoles, N.; Sanz, O.P.; Sica, R.E. 1997: Severe cardiac failure in Kearns-Sayre syndrome Medicina 57(1): 67-71
Gal, R.; Lahat, E. 2000: Progressive ptosis in children as a presenting sign of Kearns-Sayre syndrome Harefuah 138(2): 108
Gillet, J.M.; Toppet, M.; Gallez, A.; Bernard, R. 1978: Conduction abnormalities in Kearns-Sayre syndrome. Observation of 2 clinical cases Acta Cardiologica 33(5): 323-329
Zenner, K.; Gold, R.; Meurers, B.; Reichmann, H. 1990: Mitochondrial encephalomyopathies. a comparison of Kearns-Sayre syndrome, MELAS and MERRF Der Nervenarzt 61(10): 597-603
Rubí-Palomares, I.; Martínez-León, M.I.; Vera-Medialdea, R.; Delgado-Marqués, M.P.; López-Ruiz, P. 2002: Kearns-Sayre syndrome: pediatric neuroradiologic findings in computed tomography and magnetic resonance imaging Anales Espanoles de Pediatria 56(2): 180-184
Cesneková, T.; Jurecka, T.; Skorkovská, K.; Tesarová, M.; Hanisková, H.; Wenchich, L.; Zámecník, J.; Zeman, J. 2011: Corneal ulceration complicating surgical correction of ptosis in patient with Kearns-Sayre syndrome--a case report Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 67(4): 133-135
Berio, A.; Piazzi, A. 2007: Facial anomalies in a patient with cytochrome-oxidase deficiency and subsequent Kearns-Sayre syndrome with growth hormone deficiency Minerva Medica 98(1): 81-85
Everding, A.S.; Kurlemann, G.; Gerding, H.; Bömbelburg, T.; Palm, D.G.; Gullotta, F.; Zierz, S. 1988: Concordance of Kearns-Sayre syndrome and Klinefelter syndrome Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 136(10): 698-700
André-Beer, M.; Fey, S.; Walch, S.; Luethgens, K.; Ostermann, T.; Lukanov, J. 2001: The Effect of Peat Components on Endocrine and Immunological Parameters and on Trace Elements - Results of Two Pilot Studies Clinical Laboratory 47(3-4): 161-167
Tokura, T. 1970: Comparative studies on biological, immunological and biochemical properties of various human chorionic gonadotropins in blood. 1 Acta Obstetrica et Gynaecologica Japonica 17(3): 186-197
Rossi, P.; Fiermonte, G.; Pierelli, F. 2003: Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial Functional Neurology 18(3): 155-159
Dragagna, G.; Saponaro, A.; Paravati, V.; Amici, A.; Ciuffetta, D.; Sucamele, D.; Paris, A.; Martelli, M. 1988: Early use of ubidecarenone in patients with cardiopathies without signs of decompensation. Metabolic and polygraphic evaluation Minerva Cardioangiologica 36(6): 311-317